Medical management of severe ulcerative colitis.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Gastroenterology Clinics of North America

• Publication date

  2004-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/J.GTC.2004.02.005PMID 15177536
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee

  2004cited by this paper
• Infliximab in steroid-resistant ulcerative colitis – a randomised controlled trial.

  2003cited by this paper
• A humanized anti-CD3 monoclonal antibody, visilizumab, for treatment of severe steroid-refractory ulcerative colitis: Preliminary results of a phase I study

  2003cited by this paper
• Leukocyte adsorptive apheresis for the treatment of active ulcerative colitis: a prospective, uncontrolled, pilot study.

  2003cited by this paper
• The clinician's guide to inflammatory bowel disease

  2003cited by this paper
• Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column.

  2003cited by this paper
• Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis

  2002cited by this paper
• The beneficial effect of azathioprine on maintenance of remission in severe ulcerative colitis

  2002cited by this paper
• Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial.

  2002cited by this paper
• Medical treatment of severe ulcerative colitis

  2002cited by this paper
• Infliximab for treatment of steroid-refractory ulcerative colitis.

  2002cited by this paper
• Efficacy of anti-tumor necrosis factor therapy in patients with ulcerative colitis.

  2002cited by this paper
• Leukocyte Apheresis Using a Centrifugal Cell Separator in Refractory Ulcerative Colitis: A Multicenter Open Label Trial

  2002cited by this paper
• Response of Refractory Colitis to Intravenous or Oral Tacrolimus (FK506)

  2002cited by this paper
• Infliximab as a Novel Therapy for Pediatric Ulcerative Colitis

  2002cited by this paper
• Review article: medical treatment of severe ulcerative colitis.

  2002cited by this paper
• Azathioprine without oral ciclosporin in the long‐term maintenance of remission induced by intravenous ciclosporin in severe, steroid‐refractory ulcerative colitis

  2002cited by this paper
• Anti-tumour necrosis factor alpha (infliximab) in the treatment of severe ulcerative colitis: result of an open study on 13 patients.

  2002cited by this paper
• Effects of Rifaximin Administration on the Intestinal Microbiota in Patients with Ulcerative Colitis

  2002cited by this paper
• The natural history of corticosteroid therapy for inflammatory bowel disease: a population-based study.

  2001cited by this paper
• Infliximab for refractory ulcerative colitis

  2001cited by this paper
• Leukocyte apheresis using a centrifugal cell separator in refractory ulcerative colitis: a multicenter open label trial.

  2001cited by this paper
• Infliximab therapy for ulcerative colitis: many unanswered questions.

  2001cited by this paper
• Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis.

  2001cited by this paper
• Cyclosporin for severe ulcerative colitis does not increase the rate of perioperative complications

  2001cited by this paper
• Infliximab therapy for ulcerative colitis: many unanswered questions

  2001cited by this paper
• Infliximab for refractory ulcerative colitis.

  2001cited by this paper
• In‐vitro cyclosporin sensitivity of proliferating lymphocytes is predictive of in‐vivo therapeutic response in ulcerative colitis

  2001cited by this paper
• Low Molecular Weight Heparin Treatment in Steroid Refractory Ulcerative Colitis: Clinical Outcome and Influence on Mucosal Capillary Thrombi

  2001cited by this paper
• Infliximab in severe steroid-refractory ulcerative colitis: a pilot study.

  2001cited by this paper
• Infliximab for patients with refractory ulcerative colitis.

  2001cited by this paper
• Infliximab in the Treatment of Severe, Steroid-Refractory Ulcerative Colitis: A Pilot Study

  2001cited by this paper
• Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: A multicenter study

  2001cited by this paper
• A prospective randomized controlled trial of intravenous ciprofloxacin as an adjunct to corticosteroids in acute, severe ulcerative colitis.

  2001cited by this paper
• Intravenous cyclosporine in severe ulcerative colitis: ready to stand alone?

  2001cited by this paper
• Oral tacrolimus treatment of severe colitis in children.

  2000cited by this paper
• Factors predictive of response to cyclosporin treatment for severe, steroid-resistant ulcerative colitis

  2000cited by this paper
• Comparison of heparin and steroids in the treatment of moderate and severe ulcerative colitis.

  2000cited by this paper
• Intravenous azathioprine in severe ulcerative colitis: a pilot study

  2000cited by this paper
• Randomized comparison of unfractionated heparin with corticosteroids in severe active inflammatory bowel disease

  2000cited by this paper
• Infliximab in Crohn's disease: first anniversary clinical experience

  2000cited by this paper
• Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: a double-blind, placebo-controlled trial.

  1999cited by this paper
• A comparison of the quality of life in patients with severe ulcerative colitis after total colectomy versus medical treatment with intravenous cyclosporin.

  1999cited by this paper
• Unfractioned heparin in the therapy of patients with highly active inflammatory bowel disease

  1999cited by this paper
• Intravenous cyclosporin in ulcerative colitis: a five-year experience

  1999cited by this paper
• Infliximab for the treatment of fistulas in patients with Crohn's disease.

  1999cited by this paper
• Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.

  1999cited by this paper
• Lack of effect of intravenous administration on time to respond to azathioprine for steroid-treated Crohn's disease. North American Azathioprine Study Group.

  1999cited by this paper
• Treatment of corticosteroid-resistant ulcerative colitis with oral low molecular weight heparin.

  1999cited by this paper
• Steroid-unresponsive acute attacks of inflammatory bowel disease: immunomodulation by tacrolimus (FK506)

  1998cited by this paper
• Efficacy and Efficiency of Oral Microemulsion Cyclosporin Versus Intravenous and Soft Gelatin Capsule Cyclosporin in the Treatment of Severe Steroid‐Refractory Ulcerative Colitis: An Open‐Label Retrospective Trial

  1998cited by this paper
• Short‐ and long‐term outcome of patients treated with cyclosporin for severe acute ulcerative colitis

  1998cited by this paper
• Granulocyte apheresis in inflammatory bowel disease: possible mechanisms of effect.

  1998cited by this paper
• Ulcerative colitis practice guidelines in adults

  1997cited by this paper
• Treatment of ulcerative colitis with an engineered human anti‐TNFα antibody CDP571

  1997cited by this paper
• A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

  1997cited by this paper
• Anti-inflammatory properties of unfractioned heparin in patients with highly active ulcerative colitis: a pilot study.

  1997cited by this paper
• Cyclosporin for severe ulcerative colitis: a user's guide.

  1997cited by this paper
• Azathioprine in steroid-resistant and steroid-dependent ulcerative colitis.

  1997cited by this paper
• Treatment of ulcerative colitis with an engineered human anti-TNFalpha antibody CDP571.

  1997cited by this paper
• A pilot study of centrifugal leukocyte apheresis for corticosteroid-resistant active ulcerative colitis.

  1997cited by this paper
• A Short-Term Study of Chimeric Monoclonal Antibody cA2 to Tumor Necrosis Factor α for Crohn's Disease

  1997cited by this paper
• Treatment of corticosteroid‐resistant ulcerative colitis with heparin —a report of 16 cases

  1997cited by this paper
• Azathioprine is useful in maintaining long-term remission induced by intravenous cyclosporine in steroid-refractory severe ulcerative colitis.

  1996cited by this paper
• Cyclosporine Monotherapy Is Effective in the Treatment of Severe Ulcerative Colitis

  1996cited by this paper
• Intravenous cyclosporine in attacks of ulcerative colitis

  1996cited by this paper
• Mechanisms of action of immunosuppressive agents: cyclosporin A, FK506, and rapamycin.

  1995cited by this paper
• The management of ulcerative colitis.

  1995cited by this paper
• Tumor necrosis factor (TNF) in inflammatory bowel disease: gene polymorphisms, animal models, and potential for anti-TNF therapy.

  1995cited by this paper
• Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

  1995cited by this paper
• Efficacy of intravenous cyclosporine for steroid refractory attacks of ulcerative colitis.

  1995cited by this paper
• Paradoxical response to heparin in 10 patients with ulcerative colitis.

  1995cited by this paper
• How effective is current medical therapy for severe ulcerative and Crohn's colitis? An analytic review of selected trials.

  1995cited by this paper
• Cyclosporine therapy for gastrointestinal disease.

  1994cited by this paper
• Cyclosporine in severe ulcerative colitis refractory to steroid therapy.

  1994cited by this paper
• Molecular and biological actions of cyclosporin A and FK506 on T cell development and function.

  1994cited by this paper
• Is there a role for antibiotics as primary therapy in Crohn's ileitis?

  1993cited by this paper
• Continuously Infused Cyclosporine at Low Dose Is Sufficient to Avoid Emergency Colectomy in Acute Attacks of Ulcerative Colitis Without the Need for High‐Dose Steroids

  1993cited by this paper
• Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

  1993cited by this paper
• Role of neutrophil-derived oxidants in the pathogenesis of intestinal inflammation

  1991cited by this paper
• The efficacy of tobramycin in the treatment of ulcerative colitis

  1990cited by this paper
• Medical decompression of toxic megacolon by "rolling". A new technique of decompression with favorable long-term follow-up.

  1988cited by this paper
• 5-Aminosalicylic acid enema in the treatment of distal ulcerative colitis, proctosigmoiditis, and proctitis.

  1987cited by this paper
• Controlled trial of intravenous metronidazole as an adjunct to corticosteroids in severe ulcerative colitis.

  1986cited by this paper
• Double blind controlled trial of oral vancomycin as adjunctive treatment in acute exacerbations of idiopathic colitis.

  1985cited by this paper
• Systemic corticosteroid therapy of ulcerative colitis.

  1985cited by this paper
• Intensive intravenous treatment of ulcerative colitis.

  1985cited by this paper
• Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease.

  1984cited by this paper
• [Hemostasis and heparin therapy in nonspecific ulcerative colitis].

  1984cited by this paper
• Nonspecific proctocolitis in northeastern Scotland: a community study.

  1983cited by this paper
• [Use of anticoagulants in the combined treatment of nonspecific ulcerative colitis].

  1982cited by this paper
• Coagulation studies in ulcerative colitis and Crohn's disease.

  1975cited by this paper
• Intensive intravenous regimen for severe attacks of ulcerative colitis.

  1974cited by this paper
• Lysosomal mechanisms of tissue injury in arthritis.

  1972cited by this paper
• Hypercoagulability associated with chronic ulcerative colitis: changes in blood coagulation factors.

  1968cited by this paper
• The course and prognosis of ulcerative colitis

  1963cited by this paper
• Cortisone and Corticotrophin in Ulcerative Colitis

  1959cited by this paper
• The course of nonspecific ulcerative colitis: review of twenty years' experience and late results.

  1957cited by this paper
• Noradrenaline in Acute Peripheral Circulatory Failure

  1956cited by this paper
• For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group

  year unknowncited by this paper

• Predictive accuracy of fecal calprotectin in assessing clinical activity and disease severity in patients with Ulcerative Colitis and Crohn’s disease

  2025cites this paper
• Apigenin and Exposure to Low Dose Gamma Radiation Ameliorate Acetic Acid-Induced Ulcerative Colitis in Rats

  2023cites this paper
• Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases

  2020cites this paper
• A comprehensive review and update on ulcerative colitis.

  2019cites this paper
• ASSOCIATION STUDY OF MIR-34B/C GENETIC VARIATION AND ULCERATIVE COLITIS IN GUILAN PROVINCE

  2017cites this paper
• Fecal calprotectin and its correlation with inflammatory markers and endoscopy in patients from India with inflammatory bowel disease

  2015cites this paper
• Surgical Management of Severe Colitis in the Intensive Care Unit

  2015cites this paper
• Pretreatment of Gymnema sylvestre revealed the protection against acetic acid-induced ulcerative colitis in rats

  2014cites this paper
• Primary ileo-anal pouch anastomosis in patients with acute ulcerative colitis

  2013cites this paper
• [Phenotype and genotype of thiopurine methyltransferase in Chilean individuals].

  2012cites this paper
• Predictive factors of response to intravenous ciclosporin in severe ulcerative colitis: the development of a novel prediction formula

  2012cites this paper
• Do we know how to use corticosteroids in acute severe ulcerative colitis?

  2012cites this paper
• Inflammatory bowel disease in military aviators: 14 cases with return to flying duty.

  2011cites this paper
• colitis due to melanosis coli

  2010cites this paper
• Overestimation of ulcerative colitis due to melanosis coli.

  2010cites this paper
• Colitis ulcerativa crónica inespecífica: últimas noticias

  2010cites this paper
• Management of Fulminant Ulcerative Colitis GASTROINTESTINAL TRACT AND ABDOMEN

  2009cites this paper
• Predictive factors of poor response to intravenous cyclosporine in steroid-refractory ulcerative colitis.

  2009cites this paper
• Do Desipramine [10,11-Dihydro-5-[3-(methylamino) propyl]-5H-dibenz[b,f]azepine monohydrochloride] and Fluoxetine [N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]-propan-1-amine] Ameliorate the Extent of Colonic Damage Induced by Acetic Acid in Rats?

  2008cites this paper
• Intestinal Mucosa-Associated Microflora in Ulcerative Colitis Patients Before and After Restorative Proctocolectomy with an Ileoanal Pouch

  2008cites this paper
• Aberrant activation of nuclear factor of activated T cell 2 in lamina propria mononuclear cells in ulcerative colitis.

  2008cites this paper
• Surgery for inflammatory bowel disease.

  2008cites this paper
• Inflammatory bowel disease in the pediatric patient.

  2007cites this paper
• Ulcerative colitis: diagnosis and treatment.

  2007cites this paper
• [Common errors in the management of outpatients with inflammatory bowel disease].

  2007cites this paper
• Errores frecuentes en el manejo del paciente grave con enfermedad inflamatoria intestinal

  2007cites this paper
• Errores frecuentes en el manejo del paciente ambulatorio con enfermedad inflamatoria intestinal

  2007cites this paper
• [Common errors in the management of the seriously ill patient with inflammatory bowel disease].

  2007cites this paper
• Use of antibiotics in the treatment of inflammatory bowel disease

  2006cites this paper
• Infliximab: Use in inflammatory bowel disease

  2005cites this paper
• The role of antibiotics in inflammatory bowel disease

  2005cites this paper
• FULMINANT ULCERATIVE COLITIS

  2005cites this paper
• Colectomía total de urgencia por colitis ulcerosa grave

  2004cites this paper